Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells

Purpose. To investigate the effects of Coenzyme Q10 (CoQ10) treatment on immortalised human corneal endothelial cells (HCEC-12). Methods. HCEC-12 cells were cultured in different concentrations of CoQ10 (0.1%, 0.2%, 0.5%, and 1.0%) and analysed using live/dead staining assay to determine appropriate...

Full description

Saved in:
Bibliographic Details
Main Authors: Mitchell Titley, Sajjad Ahmad, Mohit Parekh
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2021/8392572
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524607887081472
author Mitchell Titley
Sajjad Ahmad
Mohit Parekh
author_facet Mitchell Titley
Sajjad Ahmad
Mohit Parekh
author_sort Mitchell Titley
collection DOAJ
description Purpose. To investigate the effects of Coenzyme Q10 (CoQ10) treatment on immortalised human corneal endothelial cells (HCEC-12). Methods. HCEC-12 cells were cultured in different concentrations of CoQ10 (0.1%, 0.2%, 0.5%, and 1.0%) and analysed using live/dead staining assay to determine appropriate concentration for subsequent experiments. Cells were pretreated with CoQ10 before inducing apoptosis by ethanol (EtOH) treatment for 30 seconds which was followed by posttreatment with CoQ10. Viable, apoptotic, and dead cell proportions were analysed using Annexin V-FITC immunofluorescence staining. Mitochondrial intensity and respiratory functions were also investigated using MitoTracker staining and a Seahorse XFe24 analyser, respectively. Results were compared to a positive control for apoptosis. The experiments were carried out in triplicates. Graphpad prism software was used for statistical analysis where p<0.05 was deemed statistically significant. Results. CoQ10 treatment at 0.5% and 1% showed 92% and 30% viable cells compared with 0.1% and 0.2% that showed 96% and 94% viable cells, respectively (p=0.0562). 0.1% and 0.2% concentrations were, thus, used for subsequent experiments. Annexin V-FITC apoptotic analysis showed 2% at 0.1% and 3% at 0.2% of apoptotic cells (p=0.0824). Mitochondrial respiratory function and mitochondrial intensity increased in apoptotic cells following 0.1% CoQ10 treatment. Conclusion. 0.1% CoQ10 was found optimal for reducing apoptosis and increasing metabolic activity on human corneal endothelial cell line. These results support the need for further ex vivo studies to investigate the safety profile of CoQ10 as an antiapoptotic agent for human corneal endothelium.
format Article
id doaj-art-2d15ca32a004442ea60b2383bc4b0c42
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-2d15ca32a004442ea60b2383bc4b0c422025-02-03T05:47:40ZengWileyJournal of Ophthalmology2090-004X2090-00582021-01-01202110.1155/2021/83925728392572Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial CellsMitchell Titley0Sajjad Ahmad1Mohit Parekh2Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UKInstitute of Ophthalmology, University College London, London, UKInstitute of Ophthalmology, University College London, London, UKPurpose. To investigate the effects of Coenzyme Q10 (CoQ10) treatment on immortalised human corneal endothelial cells (HCEC-12). Methods. HCEC-12 cells were cultured in different concentrations of CoQ10 (0.1%, 0.2%, 0.5%, and 1.0%) and analysed using live/dead staining assay to determine appropriate concentration for subsequent experiments. Cells were pretreated with CoQ10 before inducing apoptosis by ethanol (EtOH) treatment for 30 seconds which was followed by posttreatment with CoQ10. Viable, apoptotic, and dead cell proportions were analysed using Annexin V-FITC immunofluorescence staining. Mitochondrial intensity and respiratory functions were also investigated using MitoTracker staining and a Seahorse XFe24 analyser, respectively. Results were compared to a positive control for apoptosis. The experiments were carried out in triplicates. Graphpad prism software was used for statistical analysis where p<0.05 was deemed statistically significant. Results. CoQ10 treatment at 0.5% and 1% showed 92% and 30% viable cells compared with 0.1% and 0.2% that showed 96% and 94% viable cells, respectively (p=0.0562). 0.1% and 0.2% concentrations were, thus, used for subsequent experiments. Annexin V-FITC apoptotic analysis showed 2% at 0.1% and 3% at 0.2% of apoptotic cells (p=0.0824). Mitochondrial respiratory function and mitochondrial intensity increased in apoptotic cells following 0.1% CoQ10 treatment. Conclusion. 0.1% CoQ10 was found optimal for reducing apoptosis and increasing metabolic activity on human corneal endothelial cell line. These results support the need for further ex vivo studies to investigate the safety profile of CoQ10 as an antiapoptotic agent for human corneal endothelium.http://dx.doi.org/10.1155/2021/8392572
spellingShingle Mitchell Titley
Sajjad Ahmad
Mohit Parekh
Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells
Journal of Ophthalmology
title Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells
title_full Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells
title_fullStr Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells
title_full_unstemmed Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells
title_short Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells
title_sort investigating the effects of coenzyme q10 on human corneal endothelial cells
url http://dx.doi.org/10.1155/2021/8392572
work_keys_str_mv AT mitchelltitley investigatingtheeffectsofcoenzymeq10onhumancornealendothelialcells
AT sajjadahmad investigatingtheeffectsofcoenzymeq10onhumancornealendothelialcells
AT mohitparekh investigatingtheeffectsofcoenzymeq10onhumancornealendothelialcells